Affichage de 1017 résultats

Description archivistique
Ernest Armstrong McCulloch fonds
Aperçu avant impression Affichage :
McCulloch, E.A. (1996) Interaction between drugs and regulators in the treatment of leukemia,' in Molecular Biology of Cancer. San Diego, CA: Academic Press, Inc., 1996. Volume 1, 1-11
McCulloch, E.A. (1996) Interaction between drugs and regulators in the treatment of leukemia,' in Molecular Biology of Cancer. San Diego, CA: Academic Press, Inc., 1996. Volume 1, 1-11
Medical Research Council of Canada. 'Regulated drug sensitivity in leukemia'.
Medical Research Council of Canada. 'Regulated drug sensitivity in leukemia'.
McCulloch, Ernest A. Norman and leukemia hematopoietic stem cells and lineages, in Stewart Sell, ed., Stem Cells Handbook.. Towata, NJ: Humana Press, 2004, 119-131
McCulloch, Ernest A. Norman and leukemia hematopoietic stem cells and lineages, in Stewart Sell, ed., Stem Cells Handbook.. Towata, NJ: Humana Press, 2004, 119-131
McCulloch, Ernest A. (2003) The Ontario Cancer Institute : successes and reverses at Sherbourne Street. Montreal: McGill-Queen's University Press, 2003. Page proofs
McCulloch, Ernest A. (2003) The Ontario Cancer Institute : successes and reverses at Sherbourne Street. Montreal: McGill-Queen's University Press, 2003. Page proofs
McCulloch, Ernest A. (2003) The Ontario Cancer Institute : successes and reverses at Sherbourne Street Montreal: McGill-Queen's University Press, c2003. Edited manusccirpt, correspndence
McCulloch, Ernest A. (2003) The Ontario Cancer Institute : successes and reverses at Sherbourne Street Montreal: McGill-Queen's University Press, c2003. Edited manusccirpt, correspndence
McCulloch. E.A. 'Fraser Mustard', a tribute letter prepared for a presentation book on him. August 2002
McCulloch. E.A. 'Fraser Mustard', a tribute letter prepared for a presentation book on him. August 2002
McCulloch, Ernest A. CFU-S: an assay for pluripotent myelopoietic stem cells, in Henatopoeitic Stem Cell Protocols, ed. Christopher A. Klug and Craig T. Jordan. Totowa, NJ: Humana Press Inc, 2002, 153-160
McCulloch, Ernest A. CFU-S: an assay for pluripotent myelopoietic stem cells, in Henatopoeitic Stem Cell Protocols, ed. Christopher A. Klug and Craig T. Jordan. Totowa, NJ: Humana Press Inc, 2002, 153-160
Curtis, J.E., D.W. Hedley, M.D. Minden, M.A. Moore and E.A. McCulloch. Antileukemic effects of buthionine sulfoximine (BSO) (NCS 326231) in vivo: a pilot study in acute myeloblastic leukemia. Draft
Curtis, J.E., D.W. Hedley, M.D. Minden, M.A. Moore and E.A. McCulloch. Antileukemic effects of buthionine sulfoximine (BSO) (NCS 326231) in vivo: a pilot study in acute myeloblastic leukemia. Draft
Hu, Z.-B., M.D. Minden and E.A. McCulloch (2000). Regulation of drug sensitivity by ribosomal protein S3a. Blood (1 February 2000) 95, 3, 1047-1055
Hu, Z.-B., M.D. Minden and E.A. McCulloch (2000). Regulation of drug sensitivity by ribosomal protein S3a. Blood (1 February 2000) 95, 3, 1047-1055
Hu, Z.-B., M.D. Minden and E.A. McCulloch (1998). Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. Blood, 92, 5 (1 September 1998), 1768-1775
Hu, Z.-B., M.D. Minden and E.A. McCulloch (1998). Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. Blood, 92, 5 (1 September 1998), 1768-1775
2000-10-30. Keynote speaker, group dinner, State of the Science Workshop on Myelodysplastic Syndromes (2000 : Rockville, MD)
2000-10-30. Keynote speaker, group dinner, State of the Science Workshop on Myelodysplastic Syndromes (2000 : Rockville, MD)
1998-05-22. "Growth factors in AML" [presenter]. International Acute Leukaemia Forum (1st : 1998 : Siguenza, Spain)
1998-05-22. "Growth factors in AML" [presenter]. International Acute Leukaemia Forum (1st : 1998 : Siguenza, Spain)
1997-01-17. 'Cancer as an evolutionary phenomenon' workshop, Santa Barbara, CA
1997-01-17. 'Cancer as an evolutionary phenomenon' workshop, Santa Barbara, CA
Journal of Clinical Investigation
Journal of Clinical Investigation
Correspondence: B-V
Correspondence: B-V
Royal Society
Royal Society
Japan Prize
Japan Prize
Stem cells and cancer': a special symposium in honour of Till, McCulloch, and Leblod, November 2004
Stem cells and cancer': a special symposium in honour of Till, McCulloch, and Leblod, November 2004
Election to Canadian Medical Hall of Fame
Election to Canadian Medical Hall of Fame
Honorary degree, University of Toronto
Honorary degree, University of Toronto
Election to the Royal Society (1999)
Election to the Royal Society (1999)
Patient Case Files: 1951-1952
Patient Case Files: 1951-1952
Patient Case Files: 1951-1952
Patient Case Files: 1951-1952
Leukemia program project
Leukemia program project
Hu, Z.-B., M.D. Minden and E.A. McCulloch (1998). Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. Blood, 92, 5 (1 September 1998), 1768-1775
Hu, Z.-B., M.D. Minden and E.A. McCulloch (1998). Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. Blood, 92, 5 (1 September 1998), 1768-1775
Backway, Karen L, Ernest A. McCulloch, Sue Chow, and David W. Hedley. (1997) Relationships between the mitochrondrial permeability transition and oxidative stress during ara-C toxicity. ? Research (June 15 1997) 2446-2451
Backway, Karen L, Ernest A. McCulloch, Sue Chow, and David W. Hedley. (1997) Relationships between the mitochrondrial permeability transition and oxidative stress during ara-C toxicity. ? Research (June 15 1997) 2446-2451
Curtis, J.E., Y. Hao, H.A. Messner, J.H. Lipton, R. Lowsky, I.C. Quirt, J.F.G. Sturgeon, B. Zanke, A.
Curtis, J.E., Y. Hao, H.A. Messner, J.H. Lipton, R. Lowsky, I.C. Quirt, J.F.G. Sturgeon, B. Zanke, A.
NCI - "Phosphorylation of BCL-2 in leukemia blast cells
NCI - "Phosphorylation of BCL-2 in leukemia blast cells
National Cancer Institute - "Leukemia program
National Cancer Institute - "Leukemia program
National Cancer Institute - projects relating to "Leukemia program: the biology of drug response"
National Cancer Institute - projects relating to "Leukemia program: the biology of drug response"
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
Correspondence
C.V. and award
C.V. and award
Journal: 1995-1996
Journal: 1995-1996
Journal: 1994-1995
Journal: 1994-1995
Long term curing: Annex Mouse Production Charts; Mouse Production Charts
Long term curing: Annex Mouse Production Charts; Mouse Production Charts
Miscellaneous Experiments; Friend Virus (RFVI, TFVI,FV2, RFV experiments); Worksheets
Miscellaneous Experiments; Friend Virus (RFVI, TFVI,FV2, RFV experiments); Worksheets
V-V160 to V-V219; ,Z, FQ and Q; RB - CD
V-V160 to V-V219; ,Z, FQ and Q; RB - CD
V-1 to V-36[effect of vinblastime sulphate]; V-V1 to V-V159 [experiments to compare; survival of CFU-S and CFU-A incubated in vitro]
V-1 to V-36[effect of vinblastime sulphate]; V-V1 to V-V159 [experiments to compare; survival of CFU-S and CFU-A incubated in vitro]
PP9 to PP50; RASB1 to 3;RT; RCS1 to 7; REP 1 to 6;IV; SR-1 to 5; T1 to T18; TUBA1 to TUBA4
PP9 to PP50; RASB1 to 3;RT; RCS1 to 7; REP 1 to 6;IV; SR-1 to 5; T1 to T18; TUBA1 to TUBA4
NZB1 to NZB50; PLET1 to 19 (Plethorization experiments); PP1 to PP8 (Pluripotentiality of marrow stem cells)
NZB1 to NZB50; PLET1 to 19 (Plethorization experiments); PP1 to PP8 (Pluripotentiality of marrow stem cells)
K1 to K18; MC; MLV1 to 3; MY; HB; N1 to N17;
K1 to K18; MC; MLV1 to 3; MY; HB; N1 to N17;
FL22 to FL34;FV14 toFV18; FT33 to FT45; AGO, Trans Virus, HN, I1 to I53, J.D. [J.M. Dawson] Epythropoietin; Sensitive cell assay experiments.
FL22 to FL34;FV14 toFV18; FT33 to FT45; AGO, Trans Virus, HN, I1 to I53, J.D. [J.M. Dawson] Epythropoietin; Sensitive cell assay experiments.
F68 to F69; FE1 to 25; FE59,RA1 to RA28;FH-1 to FH17; FL1 to FL26 (Loose photoprints of microscopic images of blood cells and x-ray film belonging to (04), have been removed to /001P(02)
F68 to F69; FE1 to 25; FE59,RA1 to RA28;FH-1 to FH17; FL1 to FL26 (Loose photoprints of microscopic images of blood cells and x-ray film belonging to (04), have been removed to /001P(02)
EK1 to EK16; NPG -1; EP1 - 28; EV-10 to 26; MUT, Fin W, F46 to F67
EK1 to EK16; NPG -1; EP1 - 28; EV-10 to 26; MUT, Fin W, F46 to F67
CU1 to CU153; DII, D13, D35I1 to 26; D35 & K5
CU1 to CU153; DII, D13, D35I1 to 26; D35 & K5
Résultats 1 à 50 sur 1017